Conversely, in the kidney, ApoE2 is associated with reduced renal function (linked to hyperlipidemia) whereas ApoE4 attenuates the risk of end-stage renal disease, independently of race and diabetic conditions [206, 207]. This evidence concerns the gene APOE and chronic kidney disease.